Meeting
2018 Gastrointestinal Cancers Symposium
Correlation of neutrophil lymphocyte ratio, platelet lymphocyte ratio and rate of change of CA 19.9 in predicting outcome for metastatic pancreatic cancer.
Authors
Andrew Peter Dean
St. John of God Hospital, Subiaco, Australia
Andrew Peter Dean , Dom Higgs , Adarsh Das , Madeline Rogers-Seeley , Sean Fennessy , Caoimhe McGarvey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Sub Track
Translational Research
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 326)
DOI
10.1200/JCO.2018.36.4_suppl.326
Abstract #
326
Poster Bd #
F11
Abstract Disclosures
Similar Posters
Poster
2020 Gastrointestinal Cancers Symposium
Association of neutrophil, platelet, and lymphocyte ratios with prognosis in metastatic pancreatic cancer.
First Author: Jessica Allen
Poster
2020 Gastrointestinal Cancers Symposium
Evaluation of the ratio of plasma fibrinogen to platelet in resectable pancreatic cancer.
First Author: Yusuke Arakawa
Poster
2018 Gastrointestinal Cancers Symposium
Neutrophil-to-lymphocyte ratio as a prognostic marker for metastatic pancreatic cancer.
First Author: Jasmin Radhika Desai
Poster
2017 ASCO Annual Meeting
Nomogram for predicting overall survival (OS) in patients (pts) treated with nab-paclitaxel (nab-P) plus gemcitabine (Gem) or Gem alone for metastatic pancreatic cancer (MPC).
First Author: David Goldstein